Letter to the Editor: CHEK2 I157T - Pluto Among Numerous Low-Risk Genetic Factors Requiring Discharge From a Range of Pathogenic Variants?

Authors:
Maxim Ivanov Atlas Oncodiagnostics, LLC, Moscow, Russia;
Moscow Institute of Physics of Technology, Dolgoprudny, Russia;

Search for other papers by Maxim Ivanov in
Current site
Google Scholar
PubMed
Close
 PhD
,
Margarita Sharova Atlas Oncodiagnostics, LLC, Moscow, Russia;
Research and Counselling Department, Research Centre for Medical Genetics, Moscow, Russia;

Search for other papers by Margarita Sharova in
Current site
Google Scholar
PubMed
Close
 MD
,
Andrea Olsen Atlas Oncodiagnostics, LLC, Moscow, Russia;

Search for other papers by Andrea Olsen in
Current site
Google Scholar
PubMed
Close
,
Alexandra Lebedeva Atlas Oncodiagnostics, LLC, Moscow, Russia;

Search for other papers by Alexandra Lebedeva in
Current site
Google Scholar
PubMed
Close
 MSc
,
Ekaterina Ignatova Atlas Oncodiagnostics, LLC, Moscow, Russia;
Department of Chemotherapy No. 2, Federal State Budgetary Institution N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russia; and
Department of Oncogenetics, Institute of Higher and Additional Professional Education, Research Centre for Medical Genetics, Moscow, Russia

Search for other papers by Ekaterina Ignatova in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Gerald Mouse Atlas Oncodiagnostics, LLC, Moscow, Russia;

Search for other papers by Gerald Mouse in
Current site
Google Scholar
PubMed
Close
, and
Vladislav Mileyko Atlas Oncodiagnostics, LLC, Moscow, Russia;

Search for other papers by Vladislav Mileyko in
Current site
Google Scholar
PubMed
Close
Restricted access
  • Collapse
  • Expand
  • 1.

    Daly MB, Pal T, Berry MP, et al. NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021. Accessed August 27, 2021. To view the most recent version, visit NCCN.org

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Richards S, Aziz N, Bale S, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405424.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Nykamp K, Anderson M, Powers M, et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med 2017;19:11051117.

  • 4.

    Han FF, Guo CL, Liu LH. The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis. DNA Cell Biol 2013;32:329335.

  • 5.

    Thompson ER, Gorringe KL, Rowley SM, et al. Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context. Sci Rep 2015;5:14800.

  • 6.

    Meeks HD, Song H, Michailidou K, et al. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers. J Natl Cancer Inst 2015;108:djv315.

  • 7.

    Shimelis H, Mesman RLS, Von Nicolai C, et al. BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Res 2017;77:27892799.

  • 8.

    Han MR, Zheng W, Cai Q, et al. Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians. Carcinogenesis 2017;38:511518.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Hu C, Hart SN, Gnanaolivu R, et al. A population-based study of genes previously implicated in breast cancer. N Engl J Med 2021;384:440451.

  • 10.

    Yang Y, Shu X, Shu XO, et al. Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry. EBioMedicine 2019;48:203211.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Southey MC, Goldgar DE, Winqvist R, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet 2016;53:800811.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 2838 875 84
PDF Downloads 1887 626 73
EPUB Downloads 0 0 0